Safety of A Pneumococcal 13-valent Conjugate Vaccine in Elderly Japanese Patients in Daily Practice: Results of A Drug Use-Results Survey-Reference-Cited by-同舟云学术

Safety of A Pneumococcal 13-valent Conjugate Vaccine in Elderly Japanese Patients in Daily Practice: Results of A Drug Use-Results Survey

Published:2022-01-20 Issue:1 Volume:96 Page:15-24
ISSN:0387-5911
Container-title:Kansenshogaku Zasshi
language:en
Short-container-title:J. J. A. Inf. D

Author:

MATSUMOTO Noriko¹,OHKURA Masayuki¹,LEE Bennett²,HAYAMIZU Tomoyuki²

Affiliation:

1. Pfizer R&D Japan G.K.

2. Pfizer Japan Inc.

Publisher

The Japanese Association for Infectious Diseases

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/kansenshogakuzasshi/96/1/96_15/_pdf

Reference20 articles.

1. 1) 総務省統計局: 1. 高齢者の人口. 総務省統計局 [Internet]. 1996 [cited 2021 Mar 29]; Available from: https://www.stat.go.jp/data/topics/topi1211.html

2. 2) 総務省統計局: 人口動態調査表5-17「死因順位別にみた性・年齢 (5歳階級) 別死亡数・死亡率 (人口10万対) 及び割合」. 政府統計の総合窓口 (e-Stat) [Internet]. 2019 [cited 2021 Mar 29]; Available from: https://www.e-stat.go.jp/stat-search/files?page=1&layout=datalist&toukei=00450011&tstat=000001028897&cycle=7&year=20190&month=0&tclass1=000001053058&tclass2=000001053061&tclass3=000001053065&result_back=1&tclass4val=0.

3. 3) 日本呼吸器学会成人肺炎診療ガイドライン2017作成委員会: 成人肺炎診療ガイドライン2017. 一般社団法人日本呼吸器学会編, 一般社団法人日本呼吸器学会, 東京, 2017; p. 175.

4. 4) Namkoong H, Ishii M, Funatsu Y, Kimizuka Y, Yagi K, Asami T, et al.: Theory and strategy for Pneumococcal vaccines in the elderly. Hum Vaccin Immunother. 2016; 12: 336-43.

5. 5) Duggan ST: Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13^®]. Drugs. 2010; 70: 1973-86.